ERBB2 and neoplasm: BC was the strongest bacterial treatment in down regulating HER-2 in LS174T cells (the same strength as trastuzumab and only second to cetuximab) but did not significantly change this tumor marker’s expression among IEC-18 cells (in contrast to the drugs).